|
Phase I study of icotinib hydrochloride (BPI-2009H), an oral EGFR tyrosine kinase inhibitor, in patients with advanced NSCLC and other solid tumors |
|
|
|
Titel: |
Phase I study of icotinib hydrochloride (BPI-2009H), an oral EGFR tyrosine kinase inhibitor, in patients with advanced NSCLC and other solid tumors |
Auteur: |
Zhao, Qiong Shentu, Jianzhong Xu, Nong Zhou, Jianya Yang, Guangdie Yao, Yinan Tan, Fenlai Liu, Dongyang Wang, Yingxiang Zhou, Jianying |
Verschenen in: |
Lung cancer |
Paginering: |
Jaargang 73 (2011) nr. 2 pagina's 8 p. |
Jaar: |
2011 |
Inhoud: |
|
Uitgever: |
Elsevier Ireland Ltd |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|